2025 annual financial data
Inovio Pharmaceuticals 2025 Operating margin
Direct answer
Operating margin was -132,871.32%.
Operating income was -86,822,104 USD and net income was -84,945,901 USD.
Operating cash flow was -88,629,430 USD.
Get free Inovio Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 65,343 USD
- Operating income
- -86,822,104 USD
- Net income
- -84,945,901 USD
- Operating cash flow
- -88,629,430 USD